Related Experiment Video
Updated: Jun 26, 2026
10:21
Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification
Published on: November 16, 2016
Bacterial Outer Membrane Vesicles: Research Advances from Biogenesis Mechanisms to Engineered Applications
Mengyuan Zhang1,2, Xin Zhao1,3, Mingsheng Tang1
1School of Public Health, Kunming Medical University, Kunming 650500, China.
Membranes
|June 25, 2026
Summary
Bacterial outer membrane vesicles (OMVs) are key to microbial survival and host interactions. This review explores their biogenesis, biological roles, and potential in biomedical engineering, highlighting challenges and future directions.
Area of Science:
- Microbiology and Biomedical Engineering
- Nanotechnology and Drug Delivery
Background:
- Gram-negative bacteria release nanostructured outer membrane vesicles (OMVs).
- OMVs play diverse roles in microbial communities and host-pathogen interactions.
- Understanding OMV biology is crucial for biomedical applications.
Purpose of the Study:
- To comprehensively review OMV biogenesis mechanisms.
- To explore the dual role of OMVs in host-pathogen interactions.
- To summarize OMV isolation techniques and engineering strategies for biomedical use.
Main Methods:
- Review of conserved OMV biogenesis mechanisms (e.g., outer membrane-peptidoglycan link disruption, periplasmic stress).
- Analysis of OMV functions as "public goods" (nutrient acquisition, antibiotic resistance) and virulence factors.
- Examination of isolation methods (ultracentrifugation, size-exclusion chromatography) and engineering strategies (genetic modification, surface functionalization).
Main Results:
- OMVs facilitate nutrient acquisition, antibiotic resistance, and horizontal gene transfer.
- Pathogenic OMVs deliver virulence factors, while symbiotic OMVs promote immune tolerance.
- Engineered OMVs show potential for enhanced biomedical delivery.
Conclusions:
- OMVs possess significant potential for biomedical applications, particularly in drug delivery.
- Challenges in standardization, batch variation, and in vivo safety need addressing.
- Future research should focus on overcoming these obstacles for therapeutic development.
Related Concept Videos
01:38Intralumenal Vesicles and Multivesicular Bodies
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:18Outer Layers of the Cell Envelope
The outermost layers of prokaryotic cells play a critical role in their survival, virulence, and interaction with the environment. These layers, often composed of polysaccharides, polypeptides, or proteins, form protective and adhesive structures that vary in organization and function.Capsules and Slime LayersCapsules are highly organized, tightly bound layers that firmly attach to the bacterial cell wall. Capsules are usually made of polysaccharides, though some are made of polypeptides. These...
01:26Bacterial Translocation and Protein Secretion
Bacterial protein secretion involves translocation systems to ensure proteins reach their designated locations, including the plasma membrane, periplasm, outer membrane, or the external environment. These translocation systems are vital for bacterial physiology, supporting processes like membrane assembly, enzymatic activity in the periplasm, and interactions with the external environment. The division of labor between Sec and Tat pathways ensures efficiency in handling proteins with diverse...
01:33Overview of Secretory Vesicles
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
00:59COP Coated Vesicles
Membrane-enclosed structures called vesicles transport proteins and lipids across the cell. The vesicles derive their cargo from the plasma membrane, Golgi, ER, or endosome. Coated vesicles are spherical, protein-coated carriers with a 50–100 nm diameter that mediate bidirectional transport between the ER and the Golgi. The distribution of proteins between the ER and Golgi complex is dynamic and is maintained by different coated vesicles. Their formation is driven by the assembly of different...